*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*
*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*
*x*                                                                     *x*
*x*            Copyright (C) 1990 University of Pennsylvania            *x*
*x*                                                                     *x*
*x*    The data in this file are part of a preliminary version of the   *x*
*x*    Penn Treebank Corpus.  Any research using this corpus or based   *x*
*x*    on it should acknowledge that fact, as well as the preliminary   *x*
*x*    nature of the corpus.                                            *x*
*x*                                                                     *x*
*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*
*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*



======================================

[ The/DT Food/NNP ]
and/CC 
[ Drug/NNP Administration/NNP ]
and/CC 
[ the/DT National/NNP Institutes/NNP ]
of/IN 
[ Health/NNP ]
unveiled/VBD 
[ a/DT long-awaited/JJ plan/NN ]
to/TO distribute/VB 
[ the/DT drug/NN DDI/NNP ]
to/TO 
[ a/DT broad/JJ number/NN ]
of/IN 
[ AIDS/NNP patients/NNS ]
while/IN 
[ tests/NNS ]
on/IN 
[ the/DT drug/NN ]
continue/VBP ./. 

======================================

[ The/DT move/NN ]
,/, cheered/VBN by/IN 
[ AIDS/NNP activists/NNS ]
,/, was/VBD delayed/VBN by/IN 
[ two/CD weeks/NNS ]
of/IN wrangling/VBG over/IN 
[ dosage/NN levels/NNS ]
,/, and/CC by/IN 
[ belated/JJ alarms/NNS ]
raised/VBN over/IN 
[ toxic/JJ side/JJ effects/NNS ]

[ that/WDT ]
had/VBD been/VBN reported/VBN in/IN 
[ the/DT scientific/JJ ]
and/CC 
[ general/JJ press/NN two/CD months/NNS ]
ago/RB ./. 

======================================

[ DDI/NNP ]
,/, or/CC 
[ dideoxyinosine/NN ]
,/, was/VBD created/VBN at/IN 
[ the/DT National/NNP Cancer/NNP Institute/NNP ]
by/IN 
[ Samuel/NNP Broder/NNP ]
and/CC 
[ Robert/NNP Yarchoan/NNP ]
,/, and/CC licensed/VBD to/TO 
[ Bristol-Myers/NNP Co./NNP ]
for/IN 
[ further/JJ development/NN ]
./. 

[ A/DT chemical/NN cousin/NN ]
of/IN 
[ AZT/NNP ]
,/, 
[ DDI/NNP ]
is/VBZ 
[ a/DT nuceoside/NN analog/NN ]
,/, 
[ a/DT false/JJ building/NN block/NN ]
of/IN 
[ DNA/NNP ]

[ that/WDT ]
gets/VBZ into/IN 
[ the/DT virus/NN 's/POS genetic/JJ material/NN ]
and/CC blocks/VBZ 
[ its/PRP$ replication/NN ]
./. 

[ DDI/NNP ]
shows/VBZ 
[ promise/NN ]
of/IN being/VBG 
[ useful/JJ ]
to/TO 
[ the/DT 40/CD %/NN ]
of/IN 
[ AIDS/NNP patients/NNS ]

[ who/WP ]
ca/MD n't/RB take/VB 
[ AZT/NNP ]
as/IN 
[ a/DT result/NN ]
of/IN 
[ toxic/JJ side/JJ effects/NNS ]
,/, mainly/RB 
[ bone/NN marrow/NN suppression/NN ]
and/CC 
[ a/DT drop/NN ]
in/IN 
[ red/JJ ]
or/CC 
[ white/JJ blood/NN cells/NNS ]
./. 

======================================

In/IN 
[ July/NNP ]
,/, 
[ the/DT phase-one/JJ safety/NN study/NN ]
of/IN 
[ the/DT experimental/JJ drug/NN ]
reported/VBD that/IN 
[ most/JJS patients/NNS ]
tolerated/VBD 
[ the/DT drug/NN ]
well/RB and/CC experienced/VBD 
[ a/DT fall/NN ]
in/IN 
[ virus/NN levels/NNS ]
in/IN 
[ the/DT blood/NN ]
,/, accompanied/VBN by/IN 
[ a/DT rise/NN ]
in/IN 
[ T4/NNP ]
and/CC 
[ T8/NNP lymphocytes/NNS ]
,/, 
[ which/WDT ]
are/VBP 
[ disease-fighting/JJ white/JJ blood/NN cells/NNS ]
./. 

However/RB ,/, 
[ the/DT study/NN ]
,/, published/VBN in/IN 
[ the/DT journal/NN Science/NNP ]
,/, said/VBD 
[ a/DT few/JJ patients/NNS ]
at/IN 
[ the/DT highest/JJS dose/NN levels/NNS ]
developed/VBD 
[ pancreatitis/NN ]
,/, 
[ an/DT inflammation/NN ]
of/IN 
[ the/DT pancreas/NN ]
,/, or/CC 
[ neuropathy/NN ]
,/, 
[ nerve/NN damage/NN ]
with/IN 
[ pain/NN ]
and/CC tingling/NN in/IN 
[ the/DT hands/NNS ]
or/CC 
[ feet/NNS ]
./. 

======================================

Under/IN 
[ terms/NNS ]
of/IN 
[ the/DT broad/JJ program/NN ]
launched/VBN yesterday/NN ,/, 
[ phase-two/JJ studies/NNS ]
for/IN 
[ efficacy/NN ]
will/MD determine/VB whether/IN 
[ the/DT drug/NN ]
is/VBZ beneficial/JJ in/IN 
[ 2,600/CD patients/NNS ]
with/IN 
[ acquired/VBN immune/JJ deficiency/NN syndrome/NN ]
or/CC 
[ AIDS-related/JJ complex/NN ]
,/, 
[ a/DT precursor/NN condition/NN ]

[ that/WDT ]
can/MD be/VB serious/JJ or/CC 
[ fatal/JJ ]
in/IN 
[ its/PRP$ own/JJ right/NN ]
./. 

[ Two/CD studies/NNS ]
will/MD compare/VB 
[ DDI/NNP ]
against/IN 
[ AZT/NNP ]
,/, and/CC 
[ a/DT third/JJ study/NN ]
will/MD compare/VB 
[ three/CD different/JJ doses/NNS ]
of/IN 
[ DDI/NNP ]
in/IN 
[ patients/NNS ]

[ who/WP ]
can/MD not/RB tolerate/VB 
[ AZT/NNP due/JJ ]
to/TO 
[ drug/NN toxicity/NN ]
./. 

======================================

Simultaneously/RB ,/, 
[ the/DT FDA/NNP ]
granted/VBD 
[ Bristol-Myers/NNP ]

[ the/DT right/NN ]
to/TO distribute/VB 
[ DDI/NNP ]
under/IN 
[ two/CD ]
related/VBN 
[ give-away/JJ plans/NNS ]
:/: 
[ a/DT treatment/NN investigational/JJ new/JJ drug/NN ]
 (/( 
[ IND/NNP ]
 )/) 
[ program/NN ]
for/IN 
[ patients/NNS ]

[ who/WP ]
can/MD not/RB take/VB 
[ AZT/NNP ]
;/: and/CC 
[ an/DT open/JJ safety/NN protocol/NN ]
for/IN 
[ patients/NNS ]
in/IN 
[ whom/WP AZT/NNP ]
failed/VBD to/TO halt/VB 
[ the/DT disease/NN ]
./. 

[ The/DT company/NN ]
declined/VBD to/TO say/VB how/WRB 
[ many/JJ people/NNS ]

[ the/DT two/CD give-away/JJ programs/NNS ]
can/MD accommodate/VB and/CC disputed/VBD 
[ a/DT ]
currently/RB rumored/VBN 
[ figure/NN ]
of/IN 
[ 5,000/CD ]
./. 

``/`` 
[ We/PRP ]
think/VBP 
[ we/PRP ]
have/VBP enough/JJ 
[ supply/NN ]
,/, ''/'' 
[ she/PRP ]
added/VBD ./. 

======================================

``/`` 
[ This/DT ]
is/VBZ 
[ a/DT tremendous/JJ step/NN ]
forward/RB ,/, ''/'' said/VBD 
[ Jay/NNP Lipner/NNP ]
,/, 
[ a/DT New/NNP York/NNP attorney/NN ]
with/IN 
[ the/DT Lambda/NNP Legal/NNP Defense/NNP Fund/NNP ]
,/, 
[ which/WDT ]
specializes/VBZ in/IN 
[ gay-rights/NNS issues/NNS ]
./. 

``/`` 
[ It/PRP ]
's/VBZ 
[ one/CD ]
of/IN 
[ the/DT most/RBS important/JJ developments/NNS ]
in/IN 
[ the/DT past/JJ two/CD years/NNS ]
because/IN 
[ it/PRP ]
responds/VBZ to/TO 
[ the/DT needs/NNS ]
of/IN 
[ people/NNS ]

[ who/WP ]
are/VBP sick/JJ ./. 

''/'' 
======================================

``/`` 
[ Access/NN ]
to/TO 
[ promising/JJ drugs/NNS ]
must/MD be/VB increased/VBN ,/, and/CC 
[ this/DT ]
is/VBZ 
[ a/DT step/NN ]
in/IN 
[ that/DT direction/NN ]
,/, ''/'' agreed/VBD 
[ Jerome/NNP Groopman/NNP ]
,/, 
[ a/DT researcher/NN ]
at/IN 
[ New/NNP England/NNP Deaconess/NNP Hospital/NNP ]
in/IN 
[ Boston/NNP ]
./. 

[ Dr./NNP Groopman/NNP ]
described/VBD 
[ the/DT drug/NN ]
as/IN ``/`` very/RB active/JJ but/CC still/RB experimental/JJ ./. 

''/'' 
[ He/PRP ]
added/VBD that/IN ``/`` 
[ physicians/NNS ]
and/CC 
[ patients/NNS ]
must/MD understand/VB not/RB only/RB 
[ its/PRP$ promise/NN ]
,/, but/CC also/RB 
[ its/PRP$ unknowns/NNS ]
./. 

''/'' 
======================================

[ Reactions/NNS ]
from/IN 
[ the/DT gay/JJ community/NN ]
and/CC 
[ patient/NN advocacy/NN groups/NNS ]
yesterday/NN offered/VBD 
[ the/DT first/JJ general/JJ affirmation/NN ]
of/IN 
[ the/DT coordinated/VBN FDA-NIH-industry/JJ actions/NNS ]
in/IN 
[ recent/JJ days/NNS ]
of/IN 
[ the/DT epidemic/NN ]
./. 

======================================

``/`` 
[ We/PRP ]
're/VBP encouraged/VBN by/IN 
[ the/DT FDA/NNP 's/POS responsiveness/NN ]
to/TO 
[ community/NN input/NN ]
on/IN 
[ DDI/NNP ]
,/, ''/'' said/VBD 
[ Timothy/NNP Sweeney/NNP ]
,/, 
[ who/WP ]
is/VBZ acting/VBG 
[ executive/JJ director/NN ]
of/IN 
[ the/DT Gay/NNP Men/NN 's/POS Health/NNP Crisis/NNP ]
,/, 
[ a/DT New/NNP York/NNP support/NN group/NN ]
./. 

[ He/PRP ]
said/VBD 
[ the/DT group/NN ]
is/VBZ n't/RB unaware/JJ of/IN 
[ toxicity/NN risks/NNS ]
attendant/JJ upon/IN 
[ such/JJ an/DT expansion/NN ]
of/IN 
[ an/DT experimental/JJ treatment/NN ]
./. 

``/`` But/CC 
[ we/PRP ]
feel/VBP that/IN 
[ this/DT process/NN ]
will/MD give/VB 
[ us/PRP answers/NNS ]
quickly/RB on/IN 
[ DDI/NNP 's/POS safety/NN ]
and/CC 
[ effectiveness/NN ]
./. 

''/'' 
======================================

While/IN 
[ the/DT Bristol-Myers/NNP plan/NN stops/NNS ]
short/JJ of/IN 
[ a/DT more/RBR ]
liberalized/VBN ``/`` 
[ parallel/JJ track/NN ]
''/'' 
[ distribution/NN ]
still/RB under/IN 
[ review/NN ]
at/IN 
[ the/DT Department/NNP ]
of/IN 
[ Health/NNP ]
and/CC 
[ Human/NNP Services/NNP ]
,/, 
[ fans/NNS ]
of/IN 
[ parallel/JJ track/NN ]
still/RB expressed/VBN 
[ satisfaction/NN ]
with/IN 
[ yesterday/NN 's/POS progress/NN ]
./. 

======================================

``/`` 
[ I/PRP ]
'm/VBP very/RB happy/JJ ,/, ''/'' said/VBD 
[ Mathilde/NNP Krim/NNP ]
,/, founding/NN 
[ co-chairperson/NN ]
of/IN 
[ the/DT American/NNP Foundation/NNP ]
for/IN 
[ AIDS/NNP Research/NNP ]
./. 

``/`` 
[ It/PRP ]
's/VBZ 
[ a/DT step/NN ]
toward/IN implementing/VBG 
[ the/DT concept/NN ]
of/IN 
[ parallel/JJ track/NN ]
,/, and/CC ensures/VBZ 
[ DDI/NNP ]
will/MD be/VB studied/VBN in/IN 
[ a/DT controlled/VBN clinical/JJ trial/NN ]
./. 

''/'' 
[ She/PRP ]
said/VBD 
[ the/DT trial/NN ]
carries/VBZ heightened/VBN 
[ importance/NN ]
in/IN 
[ view/NN ]
of/IN 
[ data/NN ]
,/, reported/VBN at/IN 
[ the/DT Montreal/NNP AIDS/NNP conference/NN last/JJ June/NNP ]
,/, that/IN 
[ AZT-resistant/JJ strains/NNS ]
of/IN 
[ virus/NN ]
retain/VBP 
[ the/DT ability/NN ]
to/TO respond/VB to/TO 
[ DDI/NNP ]
./. 

======================================

But/CC even/RB as/IN 
[ excitement/NN ]
was/VBD mounting/VBG in/IN 
[ the/DT patient/NN population/NN ]
about/IN 
[ imminent/JJ access/NN ]
to/TO 
[ DDI/NNP ]
,/, 
[ a/DT group/NN ]
of/IN 
[ academic/JJ investigators/NNS ]
allied/VBN with/IN 
[ the/DT AIDS/NNP Clinical/NNP Trial/NNP Group/NNP ]
were/VBD growing/VBG 
[ restive/JJ ]
in/IN 
[ recent/JJ weeks/NNS ]
./. 

Worried/VBN about/IN 
[ a/DT popular/JJ ]
and/CC 
[ uncritical/JJ embrace/NN ]
of/IN 
[ the/DT drug/NN ]
,/, 
[ they/PRP ]
began/VBD 
[ private/JJ circulation/NN ]
of/IN 
[ a/DT letter/NN ]
damning/VBG 
[ the/DT effort/NN ]
and/CC raising/VBG anew/RB 
[ the/DT specter/NN ]
of/IN 
[ toxicity/NN ]
--/: 
[ much/JJ ]
of/IN 
[ it/PRP ]
at/IN 
[ high/JJ doses/NNS ]
 (/( above/IN 
[ the/DT current/JJ 750/CD mg/NN ]
per/IN 
[ day/NN ceiling/NN ]
 )/) 
[ that/WDT ]
were/VBD already/RB abandoned/VBN ./. 

======================================

``/`` 
[ DDI/NNP ]
swept/VBD through/IN with/IN 
[ a/DT lot/NN ]
of/IN 
[ enthusiasm/NN ]
,/, ''/'' said/VBD 
[ Thomas/NNP Merigan/NNP ]
,/, 
[ professor/NN ]
of/IN 
[ medicine/NN ]
at/IN 
[ Stanford/NNP University/NNP ]
./. 

``/`` When/WRB 
[ you/PRP ]
initiate/VBP 
[ wide/JJ use/NN ]

[ you/PRP ]
run/VBP 
[ a/DT risk/NN ]
./. 

''/'' 
[ He/PRP ]
acknowledged/VBD 
[ he/PRP ]
now/RB is/VBZ satisfied/VBN with/IN 
[ the/DT dose/NN levels/NNS ]
in/IN 
[ the/DT trial/NN ]
,/, especially/RB since/IN 
[ Bristol/NNP ]
agreed/VBD to/TO include/VB 
[ a/DT 500/CD mg/NN dose/NN  ]
in/IN 
[ the/DT study/NN ]
./. 

But/CC 
[ he/PRP ]
cautioned/VBD that/IN even/RB at/IN 
[ moderate/JJ doses/NNS ]
,/, 
[ toxicity/NN ]
can/MD appear/VB over/IN 
[ time/NN ]
./. 

======================================

[ Dr./NNP Yarchoan/NNP ]
,/, 
[ who/WP ]
has/VBZ tested/VBN and/CC reported/VBN 
[ DDI/NNP 's/POS effects/NNS ]
in/IN 
[ many/JJ patients/NNS ]
,/, reiterated/VBN yesterday/NN that/IN out/IN of/IN 
[ 30/CD patients/NNS ]
tested/VBN at/IN 
[ the/DT 500/CD mg/NN ]
to/TO 
[ 750/CD mg/NN dose/NN range/NN ]
,/, only/RB 
[ one/CD patient/NN ]
developed/VBD 
[ pancreatitis/NN ]
,/, with/IN 
[ some/DT ]
vomiting/NN and/CC elevated/VBN 
[ enzymes/NNS ]
./. 

[ No/DT patients/NNS ]
suffered/VBD 
[ neuropathy/NN ]
at/IN 
[ that/DT dose/NN range/NN ]
,/, and/CC 
[ those/DT ]

[ who/WP ]
had/VBD 
[ nerve/NN pain/NN ]
at/IN 
[ higher/JJR doses/NNS ]
got/VBD 
[ relief/NN ]
when/WRB 
[ the/DT drug/NN ]
was/VBD stopped/VBN ./. 

======================================

``/`` From/IN 
[ my/PRP$ experience/NN ]
,/, 
[ doses/NNS ]
selected/VBN for/IN 
[ the/DT trial/NN ]
and/CC for/IN 
[ the/DT treatment/NN IND/NNP ]
and/CC 
[ open/JJ safety/NN protocol/NN ]
are/VBP 
[ doses/NNS ]

[ that/WDT ]
are/VBP well/RB tolerated/VBN and/CC show/VB 
[ activity/NN ]
against/IN 
[ the/DT virus/NN ]
./. 

''/'' 
======================================

In/IN 
[ addition/NN ]
to/TO 
[ lowering/VBG virus/NN levels/NNS ]
and/CC 
[ boosting/VBG levels/NNS ]
of/IN 
[ immune/JJ cells/NNS ]
,/, 
[ Drs./NNP Yarchoan/NNP ]
and/CC 
[ Philip/NNP Pizzo/NNP ]
of/IN 
[ the/DT cancer/NN institute/NN ]
have/VBP reported/VBN at/IN 
[ recent/JJ scientific/JJ meetings/NNS ]

[ the/DT reversal/NN ]
of/IN 
[ AIDS/NNP dementia/NN ]

[ both/DT ]
in/IN 
[ adults/NNS ]
and/CC in/IN 
[ children/NNS ]
./. 

======================================

[ Dr./NNP Broder/NNP ]
,/, 
[ director/NN ]
of/IN 
[ the/DT cancer/NN institute/NN ]
,/, said/VBD that/IN notwithstanding/IN 
[ community/NN enthusiasm/NN ]
or/CC 
[ disputes/NNS ]
over/IN 
[ dosage/NN ]
,/, ``/`` 
[ the/DT only/JJ way/NN ]

[ we/PRP ]
're/VBP going/VBG to/TO make/VB 
[ progress/NN ]
with/IN 
[ this/DT ]
or/CC 
[ any/DT drug/NN ]
is/VBZ to/TO do/VB 
[ controlled/VBN trials/NNS ]
./. 
